News | Implantable Cardiac Monitor (ICM) | May 06, 2019

Abbott Launches Next-generation Confirm RX Implantable Cardiac Monitor

Smartphone-compatible ICM offers more accurate, 24/7 monitoring of heart rhythm disorders

Abbott Launches Next-generation Confirm RX Implantable Cardiac Monitor

May 6, 2019 — Abbott announced the launch of a new, smarter heart monitor for better arrhythmia detection — positive news for people at risk for irregular heartbeats. Now with CE Mark in Europe and U.S. Food and Drug Administration (FDA) clearance, the next-generation Confirm Rx insertable cardiac monitor (ICM), a paperclip-sized implantable device, combines smartphone connectivity and continuous, remote monitoring to track unpredictable heart rhythm problems for fast and accurate diagnosis.

An arrhythmia is an abnormal heart rhythm that can lead to symptoms such as the feeling that the heart is racing, dizziness, shortness of breath or fainting. Living with an irregular heartbeat can lead to constant questions for people battling symptoms. For the 33.5 million people living with atrial fibrillation (AFib) — the most common arrhythmia — many do not even know they have the condition.

Inserted just under the skin in the chest above the heart during a quick, minimally invasive outpatient procedure, the Confirm Rx ICM device is the only ICM on the market, according to Abbott, that syncs to a smartphone via Bluetooth and transmits information to the physician to help identify irregular heartbeats quickly. Abbott's mobile app eliminates the need for an additional transmitter and is user-friendly health technology translated in nearly 40 languages.

Wearables used to track cardiac arrhythmias have limitations when it comes to making a clinical diagnosis. Many require recharging at night, which can lead to missing irregular heartbeats that may occur sporadically and infrequently. Others require some level of interaction by the person to record symptoms, which may not be top of mind when feeling light headed, dizzy or experiencing a rapid heart rate.

"The rise in health monitoring has undoubtedly increased awareness of arrhythmias such as AFib, but many of these devices still aren't leading to an improved diagnosis or solving the key clinical challenges for people at risk," said Sean Beinart, M.D., a cardiologist with Adventist Healthcare in Rockville, Md. "Like a guardian for heart health, Confirm Rx ICM can relay important data about a person's heart rhythm through their smartphone and alert their care team to a potentially dangerous heart event. With Abbott’s new technology, I can better identify risk — making it actionable for me and life-changing for my patient."

Unlike other monitoring technology that can lead to gaps in arrhythmia detection, Confirm Rx ICM provides continuous 24/7 monitoring. The new detection technology in Confirm Rx ICM reduces false detection by 97 percent and avoids alerting physicians of irregular heartbeats that may not actually signal a cardiac arrhythmia. The next-generation version of Abbott's Confirm Rx ICM incorporates new SharpSense technology.

Approximately 6 million Americans are afflicted with irregular heartbeats, including 28-year-old Becca Bartling. Choosing Abbott’s Confirm Rx ICM meant that she could continue doing yoga, mountain biking and managing a resort on her family’s fourth-generation cranberry farm in rural Manitowish Waters, Wis. Becca said she chose Confirm Rx ICM for its convenience as there’s no need for additional monitoring equipment or a recharging station. There is also no need to rely on the patient to take action, carry a remote or go to sleep next to a separate bedside transmitter. After hearing that her Confirm Rx device would be compatible with an app on her phone, she immediately told her doctor: "I definitely want the Confirm Rx, I want that one. This device is a better option because of my lifestyle."

David Bartling, Becca's husband, recalled a fainting episode during the first week of having the device. "It was the scariest thing that I saw when she would just seem fine and the next thing you know she passed out," David said. "The Confirm Rx helped us feel comfortable with getting answers we were looking for. It’s reassuring because it's simple, small and new technology."

Becca's physician took the data and was able to quickly identify the cause of her fainting: bradycardia, which means her heart was beating too slowly and causing her to pass out. After her accurate diagnosis with the help of Confirm Rx ICM, Becca received an Abbott pacemaker to manage her condition and allow her to return to harvesting the cranberry farm and leading a fuller life.

For more information: www.cardiovascular.abbott

 

Related Implantable Cardiac Monitor Content

Confirm RX First Implantable Cardiac Monitor to Gain Approval Using Mobile Phone App Monitoring

VIDEO: Editor's Choice of Most Innovative New Technology at ACC.17

Implantable Cardiac Monitors Detect High Rate of Atrial Fibrillation in Previously Undiagnosed High-Risk Patients

VIDEO: Advances in Electrophysiology Technology

Related Content

FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.
79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event

79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event. Image courtesy of University Hospitals.

News | Cardiac Diagnostics | October 16, 2019
Health and wellness screenings are more than just nice events for the community – they can save lives. A Mentor, Ohio,...
Pesticide Exposure May Increase Heart Disease and Stroke Risk

Image courtesy of zefe wu from Pixabay

News | Cardiac Diagnostics | October 15, 2019
On-the-job exposure to high levels of pesticides raised the risk of heart disease and stroke in a generally healthy...
World Heart Federation Launches Global Roadmap on Cardiovascular Disease Prevention Among Diabetics
News | Cardiac Diagnostics | September 04, 2019
At the European Society of Cardiology (ESC) Congress 2019 together with the World Congress of Cardiology, the World...
Insomnia Tied to Higher Risk of Heart Disease and Stroke

Image courtesy of the American Heart Association

News | Cardiac Diagnostics | August 19, 2019
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke,...
Evolutionary Gene Loss May Help Explain Human Predisposition to Heart Attacks
News | Cardiac Diagnostics | July 29, 2019
The loss of a single gene two to three million years ago in our ancestors may have resulted in a heightened risk of...
U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
Overlay Init